AWM
JAZZ icon

Atticus Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Atticus Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6
Closed -$1K – 431
2021
Q2 		$1K Buy
+6
New +$1.04K ﹤0.01% 367

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Atticus Wealth Management's JAZZ Position: Q3 2021 in Review

Atticus Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 6 shares — an estimated $1K sold.

Atticus Wealth Management first reported a position in JAZZ in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • Atticus Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Atticus Wealth Management sold 6 Jazz Pharmaceuticals shares in Q3 2021, an estimated $1K.
  • Atticus Wealth Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • Atticus Wealth Management's Jazz Pharmaceuticals position peaked at $1K in Q2 2021.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Atticus Wealth Management's 13F filing for Q3 2021, filed 18 Oct 2021.